{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:18:31Z","timestamp":1793726311000,"version":"4.6.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05594-1","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T02:40:33Z","timestamp":1782355233000},"page":"20099-20103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bridging evidence and practice in heart failure care: barriers and pragmatic solutions to guideline-directed medical therapy implementation in India and other low-resource settings"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2329-2956","authenticated-orcid":false,"family":"Maryam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"4","key":"5594_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.008971","volume":"15","author":"A Agarwal","year":"2022","unstructured":"Agarwal A, Husain MJ, Datta B, Kishore SP, Huffman MD (2022) Access to heart failure medicines in low- and middle-income countries: an analysis of essential medicines lists, availability, price, and affordability. Circ Heart Fail 15(4):e008971. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.008971","journal-title":"Circ Heart Fail"},{"issue":"1","key":"5594_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jchf.2019.08.007","volume":"8","author":"P Goyal","year":"2020","unstructured":"Goyal P, Kneifati-Hayek J, Archambault A, Mehta K, Levitan EB, Chen L, Diaz I, Hollenberg J, Hanlon JT, Lachs MS, Maurer MS, Safford MM (2020) Prescribing patterns of heart failure-exacerbating medications following a heart failure hospitalization. JACC Heart Fail 8(1):25\u201334. https:\/\/doi.org\/10.1016\/j.jchf.2019.08.007","journal-title":"JACC Heart Fail"},{"issue":"Suppl 1","key":"5594_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ihj.2018.05.003","volume":"70","author":"S Guha","year":"2018","unstructured":"Guha S, Harikrishnan S, Ray S, Sethi R, Ramakrishnan S, Banerjee S, Bahl VK, Goswami KC, Banerjee AK, Shanmugasundaram S, Kerkar PG, Seth S, Yadav R, Kapoor A, Mahajan AU, Mohanan PP, Mishra S, Deb PK, Narasimhan C, Pancholia AK, Lokhandwala Y (2018) CSI position statement on management of heart failure in India. Indian Heart J 70(Suppl 1):S1\u2013S72. https:\/\/doi.org\/10.1016\/j.ihj.2018.05.003","journal-title":"Indian Heart J"},{"issue":"18","key":"5594_CR4","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, ACC\/AHA Joint Committee Members (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145(18):e895\u2013e1032","journal-title":"Circulation"},{"issue":"2","key":"5594_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40119-024-00367-4","volume":"13","author":"P Jain","year":"2024","unstructured":"Jain P, Guha S, Kumar S, Sawhney JPS, Sharma K, Sureshkumar KP, Mehta A, Dhediya R, Gaurav K, Mittal R, Kotak B (2024) Management of heart failure in a resource-limited setting: expert opinion from India. Cardiol Ther 13(2):243\u2013266. https:\/\/doi.org\/10.1007\/s40119-024-00367-4","journal-title":"Cardiol Ther"},{"issue":"2","key":"5594_CR6","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1161\/CIR.0000000000000579","volume":"138","author":"JW Magnani","year":"2018","unstructured":"Magnani JW, Mujahid MS, Aronow HD, Cen\u00e9 CW, Dickson VV, Havranek E, Morgenstern LB, Paasche-Orlow MK, Pollak A, Willey JZ, American Heart Association Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Stroke Council (2018) Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: a scientific statement from the American Heart Association. Circulation 138(2):e48\u2013e74. https:\/\/doi.org\/10.1161\/CIR.0000000000000579","journal-title":"Circulation"},{"issue":"11","key":"5594_CR7","doi-asserted-by":"publisher","first-page":"882","DOI":"10.2459\/JCM.0000000000001018","volume":"21","author":"M Mapelli","year":"2020","unstructured":"Mapelli M, Salvioni E, de Martino F, Mattavelli I, Bonomi A, Sassi V, Gugliandolo P, Vignati C, Magini A, Rovai S, Paolillo S, Agostoni P (2020) Sacubitril\/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction. Journal of cardiovascular medicine (Hagerstown, Md.) 21(11):882\u2013888. https:\/\/doi.org\/10.2459\/JCM.0000000000001018","journal-title":"Journal of cardiovascular medicine (Hagerstown, Md.)"},{"key":"5594_CR8","doi-asserted-by":"publisher","unstructured":"Maryam Varghese TP, Tazneem B, Reddy GR (2025) Emerging role of weight-loss medications in the management of heart failure: current evidence and future perspectives.\u00a0American journal of cardiovascular drugs : drugs, devices, and other interventions,\u00a025(5), 593\u2013600. https:\/\/doi.org\/10.1007\/s40256-025-00735-y","DOI":"10.1007\/s40256-025-00735-y"},{"issue":"36","key":"5594_CR9","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, de Boer RA, Christian Schulze P, Abdelhamid M, Aboyans V, Adamopoulos S, Anker SD, Arbelo E, Asteggiano R, Bauersachs J, Bayes-Genis A, Borger MA, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale CP, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis BS, Leyva F, Linhart A, L\u00f8chen M-L, Lund LH, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen J-C, Neubeck L, Noutsias M, Petersen SE, Sonia Petronio A, Ponikowski P, Prescott E, Rakisheva A, Richter DJ, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa-Uva M, Tocchetti CG, Touyz RM, Tschoepe C, Waltenberger J, Piepoli MF, Skibelund AK, ESC Scientific Document Group (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"5594_CR10","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.2147\/PPA.S222176","volume":"13","author":"FL Mondesir","year":"2019","unstructured":"Mondesir FL, Levitan EB, Malla G, Mukerji R, Carson AP, Safford MM, Turan JM (2019) Patient perspectives on factors influencing medication adherence among people with coronary heart disease (CHD) and CHD risk factors. Patient Prefer Adherence 13:2017\u20132027. https:\/\/doi.org\/10.2147\/PPA.S222176","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"5594_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11897-017-0323-2","volume":"14","author":"DR Parajuli","year":"2017","unstructured":"Parajuli DR, Franzon J, McKinnon RA, Shakib S, Clark RA (2017) Role of the pharmacist for improving self-care and outcomes in heart failure. Curr Heart Fail Rep 14(2):78\u201386. https:\/\/doi.org\/10.1007\/s11897-017-0323-2","journal-title":"Curr Heart Fail Rep"},{"issue":"17","key":"5594_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14176034","volume":"14","author":"S Patel","year":"2025","unstructured":"Patel S, Huang M, Miliara S (2025) Understanding treatment adherence in chronic diseases: challenges, consequences, and strategies for improvement. J Clin Med 14(17):6034. https:\/\/doi.org\/10.3390\/jcm14176034","journal-title":"J Clin Med"},{"issue":"6","key":"5594_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.22270\/jddt.v12i6.5730","volume":"12","author":"AB S A","year":"2022","unstructured":"S A AB, John A (2022) Beta blockers in HF, reduced EF and increased HR. J Drug Deliv Ther 12(6):224\u2013226. https:\/\/doi.org\/10.22270\/jddt.v12i6.5730","journal-title":"J Drug Deliv Ther"},{"issue":"1","key":"5594_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5334\/gh.1355","volume":"19","author":"G Satheesh","year":"2024","unstructured":"Satheesh G, Dhurjati R, Alston L, Tesfay F, Pant R, Bahiru E, Bambs C, Agarwal A, Peters SAE, Salam A, Johansson I (2024) Use of guideline-recommended heart failure drugs in high-, middle-, and low-income countries: a systematic review and meta-analysis. Glob Heart 19(1):74. https:\/\/doi.org\/10.5334\/gh.1355","journal-title":"Glob Heart"},{"issue":"5","key":"5594_CR15","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jacbts.2021.10.018","volume":"7","author":"A Sharma","year":"2022","unstructured":"Sharma A, Verma S, Bhatt DL, Connelly KA, Swiggum E, Vaduganathan M, Zieroth S, Butler J (2022) Optimizing foundational therapies in patients with HFrEF. JACC Basic Transl Sci 7(5):504\u2013517. https:\/\/doi.org\/10.1016\/j.jacbts.2021.10.018","journal-title":"JACC Basic Transl Sci"},{"issue":"3","key":"5594_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2019-000908","volume":"9","author":"S Srivastava","year":"2020","unstructured":"Srivastava S, Datta V, Garde R, Singh M, Sooden A, Pemde H, Jain M, Shivkumar P, Bang A, Kumari P, Makhija S, Ravi T, Mehta S, Garg BS, Mehta R (2020) Development of a hub and spoke model for quality improvement in rural and urban healthcare settings in India: a pilot study. BMJ Open Qual 9(3):e000908. https:\/\/doi.org\/10.1136\/bmjoq-2019-000908","journal-title":"BMJ Open Qual"},{"key":"5594_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcrp.2025.200555","volume":"28","author":"GY Tarekegn","year":"2025","unstructured":"Tarekegn GY, Chelkeba L, Deko MD, Dagnew FN, Dagnew SB, Moges TA, Anberbr SS, Yazie TS, Ayen AA, Tesfaye BT (2025) Assessment of prescriber adherence to guideline-directed medical therapy for heart failure at Jimma Medical Center, Ethiopia. Int J Cardiol Cardiovasc Risk Prev 28:200555. https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200555","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"issue":"3","key":"5594_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40256-024-00646-4","volume":"24","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Wang C, Tu T, Lin Q, Zhou J, Huang Y, Wu K, Zhang Z, Zuo W, Liu N, Xiao Y, Liu Q (2024) Advancing guideline-directed medical therapy in heart failure: overcoming challenges and maximizing benefits. Am J Cardiovasc Drugs 24(3):329\u2013342. https:\/\/doi.org\/10.1007\/s40256-024-00646-4","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05594-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05594-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05594-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:11:37Z","timestamp":1789978297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05594-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5594"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05594-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Written consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}